NRG Therapeutics partners with Domainex to develop neurodegenerative disease treatment
PMLive Read more
NRG Therapeutics selects Domainex for project aimed at finding candidate for neurogenerative disorders
Labiotech Read more
NRG Therapeutics to develop small molecule disease-modifying medicines for debilitating chronic neurodegenerative disorders
Drug Target Review
£2.68M Award to NRG Therapeutics Supports Work Into Potential DMT
Parkinson’s News Today Read more
Award to help NRG Therapeutics develop new Parkinson’s and Motor Neurone Disease treatments
Labiotech Read more
NRG receives £2.68m funding boost for neurodegenerative disorders
Pharma Times Read more
Sticking plaster for brain could beat Parkinson’s disease
Sunday Times Read more (behind a paywall)
NRG Therapeutics awarded £2.68m to fight Parkinson’s and MND
Business Weekly Read more
Cambridge neuroscience specialist NRG Therapeutics secures $500,000 from The Michael J Fox Foundation for Parkinson’s Research
Cambridge Independent Read more
© NRG Therapeutics
